EverydayHealthLogo
Dr. Norman Lacayo, MD

Dr. Norman Lacayo, MD

Palo Alto, CA

Accepting patients

    Who is Dr. Lacayo, Pediatric Hematologist-Oncologist in Palo Alto, CA?

    Dr. Norman Lacayo, MD is a Pediatric Hematologist-Oncologist, who primarily practices in Palo Alto, CA. He is board certified. Dr. Lacayo graduated from University of California and completed his residency at Stanford Univ Hosp, Pediatric Hematology-Oncology; Univ Ca Sf Med Ctr, Pediatrics. Dr. Lacayo is fluent in English and Spanish, and is currently seeing new patients. Dr. Lacayo’s practice accepts Kaiser Permanente, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Lacayo’s office at (650) 497-8000.

    Where did Dr. Lacayo go to medical school and complete their residency?

    • Residency: Stanford Univ Hosp, Pediatric Hematology-Oncology; Univ Ca Sf Med Ctr, Pediatrics

    • Medical School: University of Ca, San Francisco, Sch of Med, San Francisco Ca | University of California

    What languages does Dr. Lacayo speak?

    Dr. Lacayo and their clinical team can communicate with patients in the following languages:

    • English

    • Spanish

    What conditions does Dr. Lacayo treat?

    As a Pediatric Hematologist-Oncologist, Dr. Lacayo diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Lacayo. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

    Also known as:

    • Acute Lymphocytic Leukemia in Remission
    • Acute Lymphoblastic Leukemia
    • Acute Myeloid Leukemia in Remission
    • Acute Leukemia in Remission
    • Acute Leukemia
    • Acute Myeloid Leukemia
    • Acute Lymphocytic Leukemia in Relapse
    • Acute Promyelocytic Leukemia in Remission
    • Acute Myeloid Leukemia in Relapse
    • Acute Promyelocytic Leukemia
    • Leukemia
    • Acute Lymphocytic Leukemia
    • Acute promyelocytic leukemia
    • ALL Leukemia in Remission
    • Acute Lymphoblastic Leukemia in Remission
    • Childhood Leukemia in Remission
    • ALL
    • Acute lymphocytic leukemia
    • Lymphoblastic leukemia
    • AML Leukemia in Remission
    • Acute Myeloblastic Leukemia in Remission
    • Acute Myelogenous Leukemia in Remission
    • Acute Blood Cancer in remission
    • Leukemia remission
    • Acute Lymphocytic Leukemia remission
    • Acute Blood Cancer
    • Undifferentiated Acute Leukemia
    • Fast-growing Blood Cancer
    • AML Leukemia
    • Acute Myeloblastic Leukemia
    • Acute Myelogenous Leukemia
    • ALL Leukemia in Relapse
    • Acute Lymphoblastic Leukemia in Relapse
    • Recurrent Childhood Leukemia
    • APL Leukemia in Remission
    • Acute Myeloid Leukemia M3 in Remission
    • Promyelocytic Leukemia in Remission
    • AML Leukemia in Relapse
    • Acute Myeloblastic Leukemia in Relapse
    • Acute Myelogenous Leukemia in Relapse
    • APL Leukemia
    • Acute Myeloid Leukemia M3
    • Promyelocytic Leukemia
    • Blood Cancer
    • Cancer of White Blood Cells
    • Leukemia types

    ICD-10 Codes:

    • C9101: Acute lymphoblastic leukemia, in remission
    • C9100: Acute lymphoblastic leukemia not having achieved remission
    • C9201: Acute myeloblastic leukemia, in remission
    • C9501: Acute leukemia of unspecified cell type, in remission
    • C9500: Acute leukemia of unspecified cell type not having achieved remission
    • C9200: Acute myeloblastic leukemia, not having achieved remission
    • C9102: Acute lymphoblastic leukemia, in relapse
    • C9241: Acute promyelocytic leukemia, in remission
    • C9202: Acute myeloblastic leukemia, in relapse
    • C9240: Acute promyelocytic leukemia, not having achieved remission
    • C9590: Leukemia, unspecified not having achieved remission

    Also known as:

    • Cancer Chemotherapy
    • Chemo treatment
    • Oncology chemotherapy
    • Cancer drug therapy

    ICD-10 Codes:

    • Z5111: Encounter for antineoplastic chemotherapy

    Also known as:

    • Cancer Follow-up Exam
    • Cancer
    • Post-cancer treatment checkup
    • Malignancy surveillance
    • Oncology follow-up

    ICD-10 Codes:

    • Z08: Encounter for follow-up examination after completed treatment for malignant neoplasm

    Also known as:

    • Adrenal Gland Cancer
    • Adrenocortical Carcinoma Treatment (PDQ)
    • Adrenocortical Carcinoma
    • Adrenal Cancer
    • Malignant Adrenal Tumor

    ICD-10 Codes:

    • C7490: Malignant neoplasm of unspecified part of unspecified adrenal gland

    Also known as:

    • Hodgkin Lymphoma
    • Hodgkin's Disease', 'Hodgkin's Lymphoma

    ICD-10 Codes:

    • C8190: Hodgkin lymphoma, unspecified, unspecified site

    Also known as:

    • Lymphoblastic Lymphoma
    • Lymphoma
    • LL
    • Precursor Lymphoblastic Lymphoma
    • Lymphoblastic Lymphoma Cancer

    ICD-10 Codes:

    • C8350: Lymphoblastic (diffuse) lymphoma, unspecified site

    Also known as:

    • Bone Cancer
    • Cancer
    • Primary Bone Cancer
    • Malignant Bone Tumor
    • Bone Sarcoma
    • Osteosarcoma

    ICD-10 Codes:

    • C419: Malignant neoplasm of bone and articular cartilage, unspecified

    Also known as:

    • Langerhans Cell Histiocytosis
    • Langerhans cell histiocytosis
    • Langerhans Cell Histiocytosis Treatment (PDQ)
    • LCH
    • Unifocal LCH

    ICD-10 Codes:

    • C966: Unifocal Langerhans-cell histiocytosis

    Also known as:

    • Soft Tissue Sarcoma
    • Cancer
    • Connective Tissue Disorder
    • Malignant Soft Tissue Tumor
    • Connective Tissue Cancer
    • Soft Tissue Cancer

    ICD-10 Codes:

    • C499: Malignant neoplasm of connective and soft tissue, unspecified

    Also known as:

    • Myelodysplastic Syndrome
    • Myelodysplastic Syndromes
    • Myelodysplastic Syndromes Treatment (PDQ®)
    • MDS
    • Preleukemia
    • Bone marrow failure disorder

    ICD-10 Codes:

    • D469: Myelodysplastic syndrome, unspecified

    Which procedures does Dr. Lacayo perform as a Pediatric Hematologist-Oncologist?

    As a Pediatric Hematologist-Oncologist, procedures performed by a Dr. Norman Lacayo may include:

    For detailed information, please contact Dr. Lacayo's office.

    Does Dr. Lacayo accept my insurance?

    Dr. Lacayo accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Lacayo accept in Palo Alto, CA?

    Dr. Lacayo in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • All Other Third Party

    • Blue Shield of California

    • California Water Service Group

    • Central California Alliance for Health

    • CVS Health (formerly Aetna)

    • Elevance Health Inc. (formerly Anthem)

    • Health Plan of San Mateo

    • OptumRx

    • Santa Clara Family Health Plan

    • UnitedHealthcare

    View All Insurances

    Where is Dr. Lacayo's office located?

    Dr. Norman Lacayo's Primary Practice

    725 Welch Rd

    Palo Alto, CA 94304

    (650) 497-8000

    Get Directions

    Recognitions

    Publications

    Development and validation of a single-cell network profiling assay

    BRITISH JOURL OF HAEMATOLOGY, 2013

    Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome

    LEUKEMIA, 2013

    AKT Sigling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab

    PLOS ONE, 2013

    Massive evolution of the immunoglobulin heavy chain locus

    BLOOD, 2012

    Assessing sigling pathways associated with in vitro resistance to cytotoxic agents in AML

    LEUKEMIA RESEARCH, 2012

    Circular Rs Are the Predomint Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types

    PLOS ONE, 2012

    Dorsolateral Midbrain MRI Abnormalities

    JOURL OF NEURO-OPHTHALMOLOGY, 2011

    A pilot study of an online cognitive rehabilitation program for executive function skills

    BRAIN INJURY, 2011

    Minimal residual disease-directed therapy for childhood acute myeloid leukaemia

    LANCET ONCOLOGY, 2010

    Phase I Study of Valspodar

    PEDIATRIC BLOOD & CANCER, 2010

    Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding

    BLOOD, 2010

    WT1 Expression at Diagnosis Does Not Predict Survival in Pediatric AML

    PEDIATRIC BLOOD & CANCER, 2009

    Speeding the Flow Toward Persolized Therapy in Childhood Acute Leukemia

    PEDIATRIC BLOOD & CANCER, 2009

    Molecular inversion probes reveal patterns of 9p21 deletion

    CANCER GENETICS AND CYTOGENETICS, 2009

    Genomics of childhood leukemias: The virtue of complexity

    JOURL OF CLINICAL ONCOLOGY, 2008

    Tissue microarrays from bone marrow aspirates for high

    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2008

    Acute leukemia in children

    DM DISEASE-A-MONTH, 2008

    The incidence and clinical significance of nucleophosmin mutations in childhood AML

    BLOOD, 2007

    Differential gene expression patterns and interaction networks in BCR-ABL

    JOURL OF CLINICAL ONCOLOGY, 2007

    CpG island methylator phenotype and childhood leukemia

    CLINICAL CANCER RESEARCH, 2006

    Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is

    LEUKEMIA, 2006

    Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission

    BLOOD, 2006

    Gene expression profiling and FLT3 status correlate with outcome in de novo acute myeloid leukemia

    Lacayo, N., Meshinchi, S., Raimondi, S., Saraiya, C., O'Brien, M., Yu,, 2005

    Gene expression profiles at diagnosis

    BLOOD, 2004

    Modulation of resistance to idarubicin by the cyclosporin PSC 833

    Jourl of experimental therapeutics & oncology, 2003

    Preferential expression of a mutant allele of the amplified MDR1

    GENES CHROMOSOMES & CANCER, 2002

    Pharmacokinetic interactions of cyclosporine with etoposide

    LEUKEMIA, 2002

    Mitoxantrone, etoposide

    JOURL OF CLINICAL ONCOLOGY, 2000

    Loss of cyclosporin

    MOLECULAR PHARMACOLOGY, 2000

    Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype

    JOURL OF BIOLOGICAL CHEMISTRY, 1997

    What is Dr. Lacayo's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Lacayo's National Provider Identifier (NPI) number is 1770648586.

    What common questions do patients ask about Dr. Lacayo?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Lacayo

    What is Dr. Norman Lacayo's specialty?

    Dr. Lacayo is a Pediatric Hematologist-Oncologist near Palo Alto, CA. A pediatrician trained in the integration of pediatrics, hematology, and oncology, specializing in the recognition and management of blood disorders and cancer in children. This expert provides comprehensive care for conditions such as anemia, bleeding disorders, and various pediatric cancers. Contact Dr. Lacayo to book an appointment today.

    Is this Dr. Norman Lacayo affiliated with a ranked Castle Connolly Top Hospital?

    No, Lacayo is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Lucile Packard Childrens Hospital Stanford. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Pediatric Hematologist-Oncologist?

    Explore Pediatric Hematologist-Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Norman Lacayo accepting new patients in Palo Alto, CA?

    Yes, Dr. Norman Lacayo is accepting new patients at this time.

    Does Dr. Norman Lacayo offer online booking?

    Please contact Dr. Lacayo's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Norman Lacayo?

    Please contact Dr. Lacayo's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.

    Other Pediatric Hematologist-Oncologist Near Palo Alto, CA

    JM

    Pediatric Hematologist-Oncologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    AG

    Pediatric Hematologist-Oncologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    RS

    Pediatric Hematologist-Oncologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    See All Specialists

    Doctors by Category

    Specialists